<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Sustained <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> (VT) is an important cause of morbidity and <z:hpo ids='HP_0001699'>sudden death</z:hpo> in patients with <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Although <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> effectively terminate VT episodes and improve survival, shocks reduce quality of life, and episodes of VT predict increased risk of <z:hpo ids='HP_0001635'>heart failure</z:hpo> and <z:hpo ids='HP_0011420'>death</z:hpo> despite effective therapy </plain></SENT>
<SENT sid="2" pm="."><plain>Patients suffering recurrent VT episodes remain a challenge </plain></SENT>
<SENT sid="3" pm="."><plain>Antiarrhytmic therapy reduces VT episodes, but it is associated with serious adverse events, and disappointing efficacy </plain></SENT>
<SENT sid="4" pm="."><plain>Catheter ablation has emerged as an important option to control recurrent VT, but major procedure-related complications, and even <z:hpo ids='HP_0011420'>death</z:hpo>, are still issues to concern </plain></SENT>
<SENT sid="5" pm="."><plain>And even with these armamentaria, some patients still have recurrent VT episodes and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> shocks </plain></SENT>
<SENT sid="6" pm="."><plain>We report on a patient with non-ischemic <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo> and recurrent <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> resistant to multiple antiarrhytmic agents, in whom <z:chebi fb="0" ids="50659">dronedarone</z:chebi> was effective in completely suppressing <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> episodes </plain></SENT>
</text></document>